- Home
- Clinical Trials
Atopic Dermatitis Studies Wellington 37
Atopic Dermatitis Study
Wellington
Do you struggle with moderate to severe itchy atopic dermatitis (eczema)?
You may be eligible to join a clinical research study evaluating a new investigational product for eczema designed to help relieve itching, reduce inflammation and improve overall skin health.
By taking part, you may gain early access to a new investigational product for eczema, receive regular study related health checks, and contribute to medical research that could benefit others struggling with eczema in the future.
Description
What to expect
Study details
Ages
18 to 65 years of age
Duration
The study runs for approximately 27 weeks, involving 15 visits to the clinic and 2 under-the-skin (subcutaneous) injections
Compensation
Participants will be compensated
Eligibility Criteria
You may qualify if you:
- Are 18 to 65 years of age
- Have a clinical diagnosis of moderate to severe atopic dermatitis (eczema) for at least 1 year
- Have eczema that cannot be adequately controlled with topical medications (or if you are unable to use topical treatments)
Other criteria applies. A member of our team will check if this study is a good fit for you.
Locations
Description
Atopic dermatitis, also known as eczema, is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.
Flare ups of symptoms can be caused by a wide range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it more susceptible to irritants.
Current treatments include topical creams and corticosteroids, but these options don’t always provide lasting relief so there is a need for more effective treatment. Momentum is conducting a clinical research study exploring a potential new medicine designed to ease eczema symptoms such as itching and inflammation and potentially restore the skin barrier.
What to expect
Participants will be randomly assigned to receive two subcutaneous (under the skin) injections of either the investigational product or a placebo (inactive substance).
You’ll attend regular clinic visits for skin assessments, blood tests and study related health checks. Your safety and well-being will be closely monitored by a professional medical team throughout the study.
Why join this clinical research study?
- Gain early access to the investigational product for eczema therapy at no cost
- Contribute to research that could improve the lives of others living with eczema
- Learn to better manage your condition
- Receive study related health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.